The company increased its outlook for 2026 adjusted earnings to $7.30 to $7.50 a share, it said in a statement Wednesday. The 30-cent increase puts the new range above Wall Street estimates.
CVS shares rose as much as 9.8% when markets opened in New York.
The company, which includes a retail pharmacy, an insurer and a pharmacy benefits manager, followed every major competitor in projecting optimism for ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
